WMB Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines 26 BioLife Solutions Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher Mistras Group MG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction KALU Q1 2026 Earnings Massive EPS Beat Drives Stock Higher Amid Strong Operational Execution